ZC3H3

Chr 8

zinc finger CCCH-type containing 3

Also known as: SMICL, ZC3HDC3

Predicted to enable DNA binding activity; R-SMAD binding activity; and zinc ion binding activity. Predicted to be involved in mRNA transport. Predicted to act upstream of or within mRNA 3'-end processing and positive regulation of activin receptor signaling pathway. Located in nucleus. [provided by Alliance of Genome Resources, Jul 2025]

ResearchGenerating clinical summary…

Clinical highlights

Interpreting a novel variant
This gene is strongly intolerant of loss-of-function variation in the population, so LoF variants warrant close attention. No curated mechanism annotation is available — see the mechanism card for the computational prediction and its caveats.Based on population constraint only.
0
Active trials
4
Pubs (1 yr)
P/LP submissions
P/LP missense
0.41
LOEUF
Mechanism
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.41LOEUF
pLI 0.470
Z-score 4.10
OE 0.22 (0.120.41)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
-0.01Z-score
OE missense 1.00 (0.941.07)
592 obs / 591.6 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?0.22 (0.120.41)
00.351.4
Missense OE?1.00 (0.941.07)
00.61.4
Synonymous OE?1.23
01.21.6
LoF obs/exp: 7 / 32.1Missense obs/exp: 592 / 591.6Syn Z: -2.88

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

ZC3H3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →